Company Filing History:
Years Active: 1996-1997
Title: Inventor Spotlight: Lawrence Weissbach
Introduction
Lawrence Weissbach is an innovative inventor based in Boston, MA. He has made significant contributions to medical and biotechnological research, holding two patents that showcase his expertise and dedication to advancing science.
Latest Patents
Weissbach's latest patents include the development of a purified nucleic acid encoding the IQGAP1 protein. This novel member of the GTPase activating protein family plays a crucial role in the diagnosis and treatment of tumors. His second patent focuses on plasmilar polypeptide and antibodies that serve as malignant cell markers, providing essential tools for cancer research and diagnostics.
Career Highlights
Throughout his career, Weissbach has worked at The General Hospital Corporation, where he has contributed to groundbreaking research in the field of molecular biology and oncology. His work has garnered attention for its potential applications in cancer treatment and diagnostics.
Collaborations
Collaborating with notable colleagues such as Andre Bernards and Jeffrey E. Settleman, Weissbach has been part of a talented team that drives innovation and research forward. Their collective efforts aim to uncover new therapeutic approaches and improve patient outcomes in the fight against cancer.
Conclusion
In summary, Lawrence Weissbach is a distinguished inventor whose work in the field of biomedicine is paving the way for new diagnostic methods and treatments. With his innovative patents and collaborations, he continues to make a profound impact in the world of medical research.